YIH
AVBP icon

Y-Intercept (HK)’s ArriVent BioPharma AVBP Stock Holding History

Y-Intercept (HK)’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Buy
+11,843
New +$350K 0.01% 1366

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s AVBP Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in ArriVent BioPharma (AVBP) in Q2 2026: 11,843 shares worth $411K. The stake represents 0.01% of the portfolio and ranks #1366 among its holdings.

158 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Y-Intercept (HK) held 11,843 shares of ArriVent BioPharma worth $411K as of Q2 2026.
  • ArriVent BioPharma was a new Y-Intercept (HK) position in Q2 2026.
  • ArriVent BioPharma made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1366 holding.
  • 158 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.